doi:10.3969/j.issn.1673-8640.2015.01.023

Abstract

CLC Number:

R446.1

Figures/Tables 5

References 8

[1]	胡亚美,江载芳. 诸福棠实用儿科学[M]. 7版.北京:人民卫生出版社,2002:108-2686.
[2]	九市儿童体格发育调查协作组,首都儿科研究所.2005年中国九市七岁以下儿童体格发育调查[J].中华儿科杂志,2007,45(8):609-614.
[3]	WHO Multicenter Growth Reference Study Group. WHO child growth standards:length/height-for-age,weight-for-age, weight-for-lengh, weight-for-height and body mass index-for-age: methods and development[EB/OL].(2006-04-27)[2011-12-14]. .
[4]	BELLIZZI MC,DIETZ WH.Workshop on childhood obesity:summary of the discussion[J].Am J Clin Nutr,1999,70(1 Part 2):173S-175S.
[5]	赵地,王天有,梁璐,等.儿童至成年体重指数变化对成年血压水平的影响[J].临床儿科杂志, 2008,26(8):682-685.
[6]	张亚钦,李辉,吴秀娟.超重和肥胖对儿童骨骼强度影响的研究[J].中国实用儿科杂志,2009,24(4):297-299.
[7]	王艳,宋文琪,徐樨巍,等.学龄前儿童红细胞系列参数及体内必需元素调查[J].中国妇幼保健,2008,23(15):2144-2147.
[8]	罗辉娥,林燕敏, 李婕,等. 0~6岁儿童血清铁、锌与全血血红蛋白的相关关系研究分析[J].中国医药指南,2011,9(25):5-6.

指标	年龄(岁)	例数	中位数	均数	男童	女童	t值	P值
身高(cm)	3~4	155	105	105.35±5.88	107.45±6.49	103.34±4.08	2.52	0.015
	5~6	146	119	117.43±5.41	119.06±3.75	116.48±6.04	3.76	0.001
体重(kg)	3~4	155	18	18.06±2.43	19.10±2.38	16.90±1.95	3.22	0.003
	5~6	146	23	22.67±3.32	24.47±3.57	21.62±2.70	2.85	0.008
BMI	3~4	155	18	16.23±1.15	16.60±1.03	15.81±1.81	2.59	0.013
	5~6	146	19	16.40±1.79	16.77±1.94	16.19±1.70	1.02	0.317

指标	年龄(岁)	例数	中位数	均数	男童	女童	t值	P值
身高(cm)	3~4	155	105	105.35±5.88	107.45±6.49	103.34±4.08	2.52	0.015
	5~6	146	119	117.43±5.41	119.06±3.75	116.48±6.04	3.76	0.001
体重(kg)	3~4	155	18	18.06±2.43	19.10±2.38	16.90±1.95	3.22	0.003
	5~6	146	23	22.67±3.32	24.47±3.57	21.62±2.70	2.85	0.008
BMI	3~4	155	18	16.23±1.15	16.60±1.03	15.81±1.81	2.59	0.013
	5~6	146	19	16.40±1.79	16.77±1.94	16.19±1.70	1.02	0.317

性别	年龄 (岁)	身高(cm)			体重(kg)			BMI
性别	年龄 (岁)	本研究	文献[2]	增长	本研究	文献[2]	增长	本研究	文献[2]	增长
男	3	105.28	106.70	-1.42	15.28	15.82	-0.54	16.36	13.91	2.45
	4	108.74	107.80	0.94	19.88	17.96	1.92	16.79	15.47	1.32
	5	120.25	114.80	5.45	24.90	20.53	4.37	17.16	15.59	1.57
	6	121.29	120.00	1.29	23.86	22.51	1.35	16.2	15.63	0.57
女	3	102.12	99.45	2.67	16.44	15.34	1.10	15.76	15.51	0.25
	4	105.70	106.83	-1.13	17.78	17.43	0.35	15.91	15.28	0.63
	5	112.60	113.56	-0.96	20.12	19.60	0.52	15.89	15.20	0.69
	6	119.75	118.90	0.85	23.75	21.55	2.20	16.61	15.24	1.37

性别	年龄 (岁)	身高(cm)			体重(kg)			BMI
性别	年龄 (岁)	本研究	文献[2]	增长	本研究	文献[2]	增长	本研究	文献[2]	增长
男	3	105.28	106.70	-1.42	15.28	15.82	-0.54	16.36	13.91	2.45
	4	108.74	107.80	0.94	19.88	17.96	1.92	16.79	15.47	1.32
	5	120.25	114.80	5.45	24.90	20.53	4.37	17.16	15.59	1.57
	6	121.29	120.00	1.29	23.86	22.51	1.35	16.2	15.63	0.57
女	3	102.12	99.45	2.67	16.44	15.34	1.10	15.76	15.51	0.25
	4	105.70	106.83	-1.13	17.78	17.43	0.35	15.91	15.28	0.63
	5	112.60	113.56	-0.96	20.12	19.60	0.52	15.89	15.20	0.69
	6	119.75	118.90	0.85	23.75	21.55	2.20	16.61	15.24	1.37

性别	年龄 (岁)	身高(cm)			体重(kg)			BMI
性别	年龄 (岁)	WHO^[3]	本研究	增长	WHO^[3]	本研究	增长	WHO^[3]	本研究	增长
男	3	99.49	105.20	5.74	15.25	15.28	0.03	15.46	16.36	0.90
	4	106.40	108.70	2.31	17.25	19.88	2.63	15.26	16.79	1.53
	5	109.96	120.25	10.29	18.34	24.90	6.56	15.19	17.16	1.97
女	3	98.66	102.10	3.46	14.87	16.44	1.57	15.35	15.76	0.41
	4	105.90	105.70	-0.19	17.07	17.78	0.71	15.29	15.91	0.62
	5	109.42	112.60	3.18	18.22	20.12	1.38	15.27	15.89	0.62

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 8

Related Articles 15

Recommended Articles

Metrics

营养情况	总体	男童	女童	t值	P值
正常	15.59±0.97	16.00±0.78	15.35±0.94	2.790	0.007
超重	16.92±0.90	16.44±0.82	17.29±0.92	-1.670	0.111
肥胖	17.69±0.59	17.76±1.53	17.52±1.40	0.301	0.770

项目	RBC	Hb	钙	铁	镁	锌
RBC	—	0.771^**	-0.051	0.082	0.066	-0.022
Hb	0.771^**	—	-0.101	0.017	0.123	0.093
钙	-0.051	-0.101	—	-0.100	-0.332^**	-0.286^**
铁	0.082	0.017	-0.100	—	0.121	0.162
镁	0.066	0.123	-0.332^**	0.121	—	0.222^*
锌	-0.022	0.093	-0.286^**	0.162	0.222^*	—

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.